The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...

Initial data from clinical trials evaluating H5N1/H5N2 live-attenuated influenza vaccine suggest that immunization of unprimed subjects is not associated with a serologic response that is markedly ...

He led vaccine trials involving 9,000 ... research interests include development of live attenuated respiratory virus vaccines for influenza, parainfluenza and RSV. He led several of the NIH ...

They found that a specific type of immune cell, called T follicular helper cells, indirectly controls the anti-influenza ... vaccine with nasal spray administration of a novel attenuated live ...

Influenza virologists around the world had for years ... scientists could have used the resurrected H1N1 virus as their starting material for development of a live, attenuated H1N1 vaccine. If the ...

Influenza virologists around the world ... H1N1 virus as their starting material for development of a live, attenuated H1N1 vaccine. If the virus in the vaccine wasn’t adequately weakened ...

Scientists have now deciphered the structure of the avian influenza ... of a viral vectored flu vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe ...

[153] a nasal spray of live attenuated influenza vaccine, which contains the live but attenuated (weakened) form of the virus. Injected vaccines induce protection based on an immune response to the ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...